Correlates of cognitive dysfunction in multiple sclerosis

Brain, Behavior, and Immunity

Volumn 24, Issue 7, 2010, Pages 1148-1155

  Heesen, C ^a   Schulz, K H ^a   Fiehler, J ^a   Von der Mark, U ^a   Otte, C ^a   Jung, R ^a   Poettgen, J ^a   Krieger, T ^a   Gold, S M ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognitive dysfunction; Cytokine production; Hypothalamo pituitary adrenal axis; Magnet resonance imaging; Multiple sclerosis

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE;

ADULT; ARTICLE; ATTENTION; BLOOD SAMPLING; COGNITIVE DEFECT; CORRELATIONAL STUDY; DEPRESSION; FATIGUE; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WORKING MEMORY;

ADRENOCORTICOTROPIC HORMONE; ADULT; ATTENTION; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COGNITION DISORDERS; COHORT STUDIES; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; DEPRESSION; DEXAMETHASONE; EXECUTIVE FUNCTION; FATIGUE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERFERON-GAMMA; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PITUITARY-ADRENAL SYSTEM; SEVERITY OF ILLNESS INDEX;

EID: 79955580922     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.05.006     Document Type: Article

References (61)

1. Amato M.P., Zipoli V., Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J. Neurol. Sci. 2006, 245:41-46.
2. Arnett P.A., Barwick F.H., Beeney J.E. Depression in multiple sclerosis: review and theoretical proposal. J. Int. Neuropsychol. Soc. 2008, 14:691-724.
3. Aschenbrenner S., Tucha O., Lange K.W. Regensburger Wortflüssigkeitstest 2000, Hogrefe, Göttingen.
4. Bailey A., Channon S., Beaumont J.G. The relationship between subjective fatigue and cognitive fatigue in advanced multiple sclerosis. Mult. Scler. 2007, 13:73-80.
5. Bardeleben U., Holsboer F. Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J. Neuroendocrinol. 1989, 1:485-488.
6. Benedict R.H., Bruce J.M., Dwyer M.G., Abdelrahman N., Hussein S., Weinstock-Guttman B., Garg N., Munschauer F., Zivadinov R. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch. Neurol. 2006, 63:1301-1306.
7. Benedict R.H., Cookfair D., Gavett R., Gunther M., Munschauer F., Garg N., Weinstock-Guttman B. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J. Int. Neuropsychol. Soc. 2006, 12:549-558.
8. Benedict R.H., Duquin J.A., Jurgensen S., Rudick R.A., Feitcher J., Munschauer F.E., Panzara M.A., Weinstock-Guttman B. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult. Scler. 2008, 14(7):940-946.
9. Benedict R.H., Ramasamy D., Munschauer F., Weinstock-Guttman B., Zivadinov R. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J. Neurol. Neurosurg. Psychiatry 2009, 80:201-206.
10. Brunner R., Schaefer D., Hess K., Parzer P., Resch F., Schwab S. Effect of corticosteroids on short-term and long-term memory. Neurology 2005, 64:335-337.
11. Brynskikh A., Warren T., Zhu J., Kipnis J. Adaptive immunity affects learning behavior in mice. Brain Behav. Immun. 2008, 22:861-869.
12. Butovsky O., Talpalar A.E., Ben-Yaakov K., Schwartz M. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol. Cell. Neurosci. 2005, 29:381-393.
13. Calabrese M., Agosta F., Rinaldi F., Mattisi I., Grossi P., Favaretto A., Atzori M., Bernardi V., Barachino L., Rinaldi L., Perini P., Gallo P., Filippi M. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch. Neurol. 2009, 66:1144-1150.
14. Chen J., Liu X. The role of interferon gamma in regulation of CD4+ T-cells and its clinical implications. Cell. Imunol. 2009, 254:85-90.
15. Chiaravalloti N.D., DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008, 7:1139-1151.
16. de Quervain D.J., Henke K., Aerni A., Treyer V., McGaugh J.L., Berthold T., Nitsch R.M., Buck A., Roozendaal B., Hock C. Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur. J. Neurosci. 2003, 17:1296-1302.
17. Feuillet L., Reuter F., Audoin B., Malikova I., Barrau K., Cherif A.A., Pelletier J. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult. Scler. 2007, 13:124-127.
18. Flachenecker P., Meissner H. Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment. Mult. Scler. 2008, 14:274-277.
19. Gold S.M., Heesen C., Schulz H., Guder U., Mönch A., Gbadamosi J., Buhmann C., Schulz K.H. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult. Scler. 2001, 7(2):119-130.
20. Gold S.M., Raji A., Huitinga I., Wiedemann K., Schulz K.H., Heesen C. Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis. J. Neuroimmunol. 2005, 165:186-191.
21. Goodkin D.E., Hertsgaard D., Seminary J. Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests. Arch. Phys. Med. Rehabil. 1988, 69:850-854.
22. Gronwall D.M. Paced auditory serial-addition task: a measure of recovery from concussion. Percept. Mot. Skills 1977, 44:367-373.
23. Heesen C., Gold S.M., Raji A., Wiedemann K., Schulz K.H. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis. Psychoneuroendocrinology 2002, 27:505-517.
24. Heesen C., Koehler G., Gross R., Tessmer W., Schulz K.H., Gold S.M. Fatigue in multiple sclerosis: altered cardiovascular and cytokine responses to cognitive stress. Mult. Scler. 2005, 11:51-57.
25. Heesen C., Nawrath L., Reich C., Bauer N., Schulz K.H., Gold S.M. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?. J. Neurol. Neurosurg. Psychiatry 2006, 77:34-39.
26. Heesen C., Gold S.M., Huitinga I., Reul J.M. Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review. Psychoneuroendocrinology 2007, 32:604-618.
27. Helmstaedter C., Lendt M., Lux S. Verbaler Lern- und Merkfähigkeitstest. Diagnostica 1999, 45(4):205-211.
28. Hoffmann M., Tittgemeyer M., von Cramon D.Y. Cognitive impairment in multiple sclerosis. Curr. Opin. Neurol. 2007, 20(30):275-280.
29. Holtzer R., Foley F. The relationship between subjective reports of fatigue and executive control in multiple sclerosis. J. Neurol. Sci. 2009, 281:46-50.
30. Julian L.J., Arnett P.A. Relationships among anxiety, depression, and executive functioning in multiple sclerosis. Clin. Neuropsychol. 2009, 23:794-804.
31. Kelley K.W., Bluthe R.M., Dantzer R., Zhou J.H., Shen W.H., Johnson R.W., Broussard S.R. Cytokine-induced sickness behavior. Brain Behav. Immun. 2003, 17(1):112-118.
32. Krupp L.B., Elkins L.E. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000, 55:934-939.
33. Kujala P., Portin R., Ruutiainen J. The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain 1997, 120(Pt. 2):289-297.
34. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
35. Lublin F.D., Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996, 46:907-911.
36. Lynch S.G., Parmenter B.A., Denney D.R. The association between cognitive impairment and physical disability in multiple sclerosis. Mult. Scler. 2005, 11:469-476.
37. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 2009, 33:355-366.
38. McEwen B.S. Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol. Aging 2002, 23:921-939.
39. Morrow S.A., Weinstock-Guttman B., Munschauer F.E., Hojnacki D., Benedict R.H. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis. Mult. Scler. 2009, 15:998-1005.
40. Multiple Sclerosis Council for Clinical Practice Guidelines, 1998. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Multiple Sclerosis Council for Clinical Practice Guidelines, Paralyzed Veterans of America, October 1998.
41. Mumford C.J., Compston A. Problems with rating scales for multiple sclerosis: a novel approach - the CAMBS score. J. Neurol. 1993, 240:209-215.
42. Parmenter B.A., Denney D.R., Lynch S.G. The cognitive performance of patients with multiple sclerosis during periods of high and low fatigue. Mult. Scler. 2003, 9:111-118.
43. Paul R.H., Beatty W.W., Schneider R., Blanco C.R., Hames K.A. Cognitive and physical fatigue in multiple sclerosis: relations between self-report and objective performance. Appl. Neuropsychol. 1998, 5:143-148.
44. Portaccio E., Stromillo M.L., Goretti B., Zipoli V., Siracusa G., Battaglini M., Giorgio A., Bartolozzi M.L., Guidi L., Sorbi S., Federico A., Amato M.P., De Stefano N. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology 2009, 73:498-503.
45. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13:227-231.
46. Radloff L.S. The CESD scale: a selfreport depression scale for research in the general population. Appl. Psychol. Meas. 1977, 3:385-401.
47. Rao S.M., Leo G.J., Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991, 41:685-691.
48. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 2001, 58:445-452.
49. Rogers J.M., Panegyres P.K. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations. J. Clin. Neurosci. 2007, 14:919-927.
50. Schmidt K.H., Metzler P. Wortschatztest (WST) 1992, Beltz Test GmbH, Weinheim.
51. Schroeter M., Jander S. T-cell cytokines in injury-induced neural damage and repair. Neuromol. Med. 2005, 7:183-195.
52. Sheline Y.I. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol. Psychiatry 2000, 48:791-800.
53. Sicotte N.L., Kern K.C., Giesser B.S., Arshanapalli A., Schultz A., Montag M., Wang H., Bookheimer S.Y. Regional hippocampal atrophy in multiple sclerosis. Brain 2008, 131:1134-1141.
54. Smith A. The Symbol Digit Modalities Test. Learn. Disabil. 1968, 3:83-91.
55. Sospedra M., Martin R. Immunology of multiple sclerosis. Ann. Rev. Immunol. 2005, 23:683-747.
56. Sperling R.A., Guttmann C.R., Hohol M.J., Warfield S.K., Jakab M., Parente M., Diamond E.L., Daffner K.R., Olek M.J., Orav E.J., Kikinis R., Jolesz F.A., Weiner H.L. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch. Neurol. 2001, 58(1):115-121.
57. Then Bergh F., Kumpfel T., Trenkwalder C., Rupprecht R., Holsboer F. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology 1999, 53:772-777.
58. Weiss H.A., Millward J.M., Owens T. CD8+ T cells in inflammatory demyelinating disease. J. Neuroimmunol. 2007, 191:79-85.
59. Wolf S.A., Steiner B., Akpinarli A., Kammertoens T., Nassenstein C., Braun A., Blankenstein T., Kempermann G. CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. J. Immunol. 2009, 182:3979-3984.
60. Ysrraelit M.C., Gaitan M.I., Lopez A.S., Correale J. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 2008, 71:1948-1954.
61. Zimmermann P., Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (Version 1.02c) 1994, Psytest, Würselen.